Literature DB >> 19309755

A DNA replicon system for rapid high-level production of virus-like particles in plants.

Zhong Huang1, Qiang Chen, Brooke Hjelm, Charles Arntzen, Hugh Mason.   

Abstract

Recombinant virus-like particles (VLPs) represent a safe and effective vaccine strategy. We previously described a stable transgenic plant system for inexpensive production and oral delivery of VLP vaccines. However, the relatively low-level antigen accumulation and long-time frame to produce transgenic plants are the two major roadblocks in the practical development of plant-based VLP production. In this article, we describe the optimization of geminivirus-derived DNA replicon vectors for rapid, high-yield plant-based production of VLPs. Co-delivery of bean yellow dwarf virus (BeYDV)-derived vector and Rep/RepA-supplying vector by agroinfiltration of Nicotiana benthamiana leaves resulted in efficient replicon amplification and robust protein production within 5 days. Co-expression of the P19 protein of tomato bush stunt virus, a gene silencing inhibitor, further enhanced VLP accumulation by stabilizing the mRNA. With this system, hepatitis B core antigen (HBc) and Norwalk virus capsid protein (NVCP) were produced at 0.80 and 0.34 mg/g leaf fresh weight, respectively. Sedimentation analysis and electron microscopy of transiently expressed antigens verified the efficient assembly of VLPs. Furthermore, a single replicon vector containing a built-in Rep/RepA cassette without P19 drove protein expression at similar levels as the three-component system. These results demonstrate the advantages of fast and high-level production of VLP-based vaccines using the BeYDV-derived DNA replicon system for transient expression in plants. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309755      PMCID: PMC2704498          DOI: 10.1002/bit.22299

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  38 in total

Review 1.  Vaccines that facilitate antigen entry into dendritic cells.

Authors:  Anita Gamvrellis; David Leong; Jennifer C Hanley; Sue D Xiang; Patricia Mottram; Magdalena Plebanski
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

Review 2.  Virus-like particles as vaccines and vessels for the delivery of small molecules.

Authors:  Robert L Garcea; Lutz Gissmann
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

Review 3.  Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead.

Authors:  Yasmin Thanavala; Zhong Huang; Hugh S Mason
Journal:  Expert Rev Vaccines       Date:  2006-04       Impact factor: 5.217

4.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Authors:  H S Mason; J M Ball; J J Shi; X Jiang; M K Estes; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

5.  Application of the human hepatitis B virus core antigen from transgenic tobacco plants for serological diagnosis.

Authors:  S Tsuda; K Yoshioka; T Tanaka; A Iwata; A Yoshikawa; Y Watanabe; Y Okada
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

6.  The amplicon-plus system for high-level expression of transgenes in plants.

Authors:  Allison C Mallory; Graham Parks; Matthew W Endres; David Baulcombe; Lewis H Bowman; Gail J Pruss; Vicki B Vance
Journal:  Nat Biotechnol       Date:  2002-06       Impact factor: 54.908

7.  An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus.

Authors:  Olivier Voinnet; Susana Rivas; Pere Mestre; David Baulcombe
Journal:  Plant J       Date:  2003-03       Impact factor: 6.417

8.  The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.

Authors:  D R Milich; A McLachlan
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

Review 9.  Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Authors:  H Daniell; S J Streatfield; K Wycoff
Journal:  Trends Plant Sci       Date:  2001-05       Impact factor: 18.313

Review 10.  Use of viral vectors for vaccine production in plants.

Authors:  M Carmen Cañizares; Liz Nicholson; George P Lomonossoff
Journal:  Immunol Cell Biol       Date:  2005-06       Impact factor: 5.126

View more
  77 in total

1.  A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge.

Authors:  Waranyoo Phoolcharoen; John M Dye; Jacquelyn Kilbourne; Khanrat Piensook; William D Pratt; Charles J Arntzen; Qiang Chen; Hugh S Mason; Melissa M Herbst-Kralovetz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.

Authors:  Waranyoo Phoolcharoen; Seong H Bhoo; Huafang Lai; Julian Ma; Charles J Arntzen; Qiang Chen; Hugh S Mason
Journal:  Plant Biotechnol J       Date:  2011-02-01       Impact factor: 9.803

3.  Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce.

Authors:  Huafang Lai; Junyun He; Michael Engle; Michael S Diamond; Qiang Chen
Journal:  Plant Biotechnol J       Date:  2011-08-26       Impact factor: 9.803

4.  Meeting report VLPNPV: Session 5: Plant based technology.

Authors:  Lydia R Meador; Tsafrir S Mor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

6.  Spurious polyadenylation of Norovirus Narita 104 capsid protein mRNA in transgenic plants.

Authors:  Lolita G Mathew; Bryan Maloney; Naokazu Takeda; Hugh S Mason
Journal:  Plant Mol Biol       Date:  2011-01-04       Impact factor: 4.076

7.  DNA replicons for plant genome engineering.

Authors:  Nicholas J Baltes; Javier Gil-Humanes; Tomas Cermak; Paul A Atkins; Daniel F Voytas
Journal:  Plant Cell       Date:  2014-01-17       Impact factor: 11.277

8.  Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.

Authors:  Andrew G Diamos; Dalia Larios; Lauren Brown; Jacquelyn Kilbourne; Hyun Soon Kim; Divyasha Saxena; Kenneth E Palmer; Hugh S Mason
Journal:  Vaccine       Date:  2018-11-17       Impact factor: 3.641

9.  Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody.

Authors:  Frank Sainsbury; Markus Sack; Johannes Stadlmann; Heribert Quendler; Rainer Fischer; George P Lomonossoff
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

Review 10.  Plant-made vaccine antigens and biopharmaceuticals.

Authors:  Henry Daniell; Nameirakpam D Singh; Hugh Mason; Stephen J Streatfield
Journal:  Trends Plant Sci       Date:  2009-10-14       Impact factor: 18.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.